Measurements Of Zinc Concentration On Specimens Taken During Trans-Perineal Prostate Biopsy
Conditions
Prostate Cancer
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Cross-Sectional
Intervention
Name: prostate biopsy
Type: Other
Overall Status
Not yet recruiting
Summary
The purposes of this study are to: i) confirm and improve the accuracy of the correlation between levels of Zinc in prostate tissue and the grade of prostate cancer in that tissue as determined through pathology; and ii) determine the levels of zinc in prostate tissue declared as non-cancerous by pathology and located in the vicinity of tissue declared as cancerous by pathology, and verify that the Zinc levels for the declared non-cancerous tissue are lower (statistically significantly) than the levels for benign tissue not in the vicinity of cancerous tissue.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 45 Years
Gender: Male
Criteria: Inclusion Criteria:

- Elevated PSA, >10ng/mL

- Subject underwent primary and at least one secondary (repeat) prostate biopsy with negative diagnosis

- Subject directed at saturated trans-perineal biopsy

Exclusion Criteria:

- Subject was under Zn supplement nutrition treatment
Location
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Status: Not yet recruiting
Start Date
October 2013
Completion Date
October 2014
Sponsors
ProSight
Source
ProSight
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page